Resultate kontinuierlicher Glukosemessungen(CGMS™) unter ambulanten Bedingungen zur Beurteilung der Stoffwechseleinstellung bei T2DM

Occurence of Adverse Events Due to Continuous Glucose Monitoring

“…Since the beginning of the third millenium, CGMS ™ , Medtronic Minimed, Northridge, CA, USA 3 and STS system, Dexcom, San Diego, CA, USA 4,5 , have made CGM, available for thousands of persons with diabetes. The transcutaneous CGMS ™ sensor is labeled to measure the glucose concentration in interstitial fl uid for up to three days after insertion even though it remains stable for a longer period [5][6][7][8][9][10][11] . On the other hand, the potential risks of adverse events due to longer insertion time should be taken into consideration.…”

Benefits of Three-Month Continuous Glucose Monitoring for Persons With Diabetes Using Insulin Pumps and Sensors

“…This discovery is in accordance with other investigations which have confirmed the superior efficacy of the Lispro insulin analog in external pumps (Humalog) 26 . Continuous glucose monitoring (CGM) during insulin pump therapy appears to be an excellent alternative for further improvement of metabolic compensation [27][28][29][30][31][32] . The advantage of this compensation control is that it enables the patient to register both average 24-hour glycemia and variability in glycemia.…”

Automated Computation of Glycemic Index for Foodstuffs Using Continuous Glucose Monitoring

“…The preliminary results of other studies show that the values of respective GIs in persons with type 1 and type 2 diabetes are not statistically different. [32][33][34][35][36] DegifXL enables one to also perform detailed data processing in persons with diabetes and/or to determine the GI values for breakfast and for dinner times, for men and women, and so on. Consumption of high glycemic index food does not seem to result in worsening of glycemic control in type 1 diabetes.…”